Immune‐enhancing supplements (oral or enteral) vs usual care or control
- Preoperative nutrition therapy in people undergoing gastrointestinal surgery 2024 · Cochrane Headline outcomes onlyno estimate extracted6 studies · 688 participantsLow
Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.
Oral nutritional supplements showed no clear difference in non‐infectious complications recorded up to 30 days postdischarge compared with usual care or control (low certainty).
It is very uncertain whether oral nutritional supplements changes infectious complications recorded up to 30 days postdischarge compared with usual care or control (very low certainty).
It is very uncertain whether preoperative parenteral nutrition changes infectious complications compared with usual care or control (very low certainty).
The review found no eligible studies for this question.
It is very uncertain whether preoperative enteral nutrition (standard formula) changes infectious complications compared with usual care or control (very low certainty).
Immune‐enhancing supplements (oral or enteral) showed no clear difference in non‐ infectious complications recorded up to 30 days postdischarge compared with usual care or control (low certainty).
Topical corticosteroids may leads to higher complete resolution of phimosis compared with placebo or no treatment (low certainty).
Topical corticosteroids may leads to higher partial resolution of phimosis compared with placebo or no treatment (low certainty).
It is very uncertain whether topical corticosteroids changes change in retractability score compared with placebo or no treatment (very low certainty).
Topical corticosteroids showed no clear difference in adverse effects (any) compared with placebo or no treatment (low certainty).